现代诊断与治疗
現代診斷與治療
현대진단여치료
Modern Diagnosis & Treatment
2015年
12期
2669-2670
,共2页
不同剂量%辛伐他汀%高血压病%高脂血症
不同劑量%辛伐他汀%高血壓病%高脂血癥
불동제량%신벌타정%고혈압병%고지혈증
Differentdoses%Simvastatin%Hypertension%Hyperlipidemia
目的 比较不同剂量辛伐他汀治疗老年高血压病合并高脂血症的疗效差异.方法选取2012年3月~2014年4月我院收治的56例老年高血压病合并高脂血症患者作为研究对象,采用随机数字表法将所选患者分为研究组和对照组,各28例,研究组给予辛伐他汀40mg/d治疗,对照组给予辛伐他汀20mg/d治疗,综合比较两组患者高血压、高脂血症治疗总有效率和不良反应情况.结果:研究组高血压、高脂血症治疗总有效率分别为92.86%、89.29%,高于对照组的75.0%、71.43%(P<0.05);两组患者不良反应发生率比较差异无统计学意义(P>0.05).结论 辛伐他汀40mg/d治疗老年高血压病合并高脂血症效果确切,优于20mg/d的剂量治疗,不增加药物不良反应,值得临床推广使用.
目的 比較不同劑量辛伐他汀治療老年高血壓病閤併高脂血癥的療效差異.方法選取2012年3月~2014年4月我院收治的56例老年高血壓病閤併高脂血癥患者作為研究對象,採用隨機數字錶法將所選患者分為研究組和對照組,各28例,研究組給予辛伐他汀40mg/d治療,對照組給予辛伐他汀20mg/d治療,綜閤比較兩組患者高血壓、高脂血癥治療總有效率和不良反應情況.結果:研究組高血壓、高脂血癥治療總有效率分彆為92.86%、89.29%,高于對照組的75.0%、71.43%(P<0.05);兩組患者不良反應髮生率比較差異無統計學意義(P>0.05).結論 辛伐他汀40mg/d治療老年高血壓病閤併高脂血癥效果確切,優于20mg/d的劑量治療,不增加藥物不良反應,值得臨床推廣使用.
목적 비교불동제량신벌타정치료노년고혈압병합병고지혈증적료효차이.방법선취2012년3월~2014년4월아원수치적56례노년고혈압병합병고지혈증환자작위연구대상,채용수궤수자표법장소선환자분위연구조화대조조,각28례,연구조급여신벌타정40mg/d치료,대조조급여신벌타정20mg/d치료,종합비교량조환자고혈압、고지혈증치료총유효솔화불량반응정황.결과:연구조고혈압、고지혈증치료총유효솔분별위92.86%、89.29%,고우대조조적75.0%、71.43%(P<0.05);량조환자불량반응발생솔비교차이무통계학의의(P>0.05).결론 신벌타정40mg/d치료노년고혈압병합병고지혈증효과학절,우우20mg/d적제량치료,불증가약물불량반응,치득림상추엄사용.
Objective To compare the difference of the different doses of simvastatin for hyperlipidemia treatment of hypertension.Methods Selected 56 cases of elderly patients with hypertension combined hyperlipidemia as the research object admitted in our hospital from March 2012 to April 2014, and using the random number table method , divided them into research group and the control group, each group had the 28 cases, the research group was treated with 40 mg/d of simvastatin, the control group was given 20 mg/d of simvastatin, and then compared the treatment total effective rate and adverse reactions of hypertension and hyperlipidemia in the two groups.Results The treatment total effective rate and adverse reactions of hypertension and hyperlipidemia in the research group were respectively 92.86%and 89.29%, were higher than 75.0% and 71.43% of control group (P<0.05); the difference of the adverse reactions between the two groups was not significant .Conclusions Elderly patients with hyperlipidemia and hypertension treated with high-dose ( 40 mg /d) of simvastatin treatment compared to smaller doses ( 20 mg /d) , the efficacy of regulation is better,does not increase the incidence of adverse reactions, is worthy of clinical promotion.